PubRank

Bruce H Mitlak

Author PubWeight™ 30.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2010 3.33
2 Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet 2013 3.31
3 Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 2002 3.15
4 Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 2003 2.38
5 Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 2005 2.02
6 Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes 2013 1.55
7 Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis. Arch Intern Med 2004 1.51
8 Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res 2007 1.49
9 Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis. Bone 2008 1.48
10 Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. J Bone Miner Res 2005 1.33
11 A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J Bone Miner Res 2015 1.23
12 Quality of life in sarcopenia and frailty. Calcif Tissue Int 2013 1.17
13 Osteosarcoma and teriparatide? J Bone Miner Res 2007 1.14
14 Femoral strength in osteoporotic women treated with teriparatide or alendronate. Bone 2011 1.03
15 Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. J Bone Joint Surg Am 2009 0.85
16 Recommendations regarding technical standards for follow-on biologics: comparability, similarity, interchangeability. Curr Med Res Opin 2009 0.84
17 Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA. Curr Med Res Opin 2010 0.82
18 Effect of Raloxifene on all-cause mortality. Am J Med 2010 0.82
19 Long-term raloxifene for postmenopausal osteoporosis. Curr Med Res Opin 2011 0.80
20 Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science. Semin Arthritis Rheum 2005 0.79
21 Comments on Initial experience with teriparatide in the United States. Curr Med Res Opin 2006 0.77
22 Pharmacogenomics in endocrinology. J Clin Endocrinol Metab 2002 0.75